Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07829861) titled 'The Effects of an Orally-Administered Probiotic on Vaginal Symptoms' on Sept. 15.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Single Group Assignment. Primary purpose: Supportive Care. Masking: Double (Participant, Investigator).
Primary Sponsor: Bonafide Health
Condition:
Vaginal Odor
Intervention:
Dietary Supplement: Orally-administered probiotic
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: July 29, 2025
Target Sample Size: 105
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07829861...